Product Information
JPI-547 (NOV 1402) is an oral anti-cancer drug targeting PARP 1/2 and Tankyrase 1/2, effective alone or with chemo and immunotherapies.
Chemical properties
Technical inquiry about: TM-T69955 JPI-547 HCl
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.